Compare MRBK & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | ANIK |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.9M | 198.9M |
| IPO Year | 2018 | 1996 |
| Metric | MRBK | ANIK |
|---|---|---|
| Price | $19.94 | $14.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $20.75 | $17.00 |
| AVG Volume (30 Days) | ★ 94.9K | 56.8K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | 30.34 | ★ 80.16 |
| EPS | ★ 0.17 | N/A |
| Revenue | $6,316,000.00 | ★ $112,819,000.00 |
| Revenue This Year | $25.40 | $5.98 |
| Revenue Next Year | $8.15 | $7.42 |
| P/E Ratio | $115.00 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $11.87 | $7.90 |
| 52 Week High | $21.59 | $16.24 |
| Indicator | MRBK | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 65.72 | 51.78 |
| Support Level | $18.32 | $13.91 |
| Resistance Level | $20.74 | $15.08 |
| Average True Range (ATR) | 0.58 | 0.51 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 76.02 | 68.98 |
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.